OBJECTIVE: Although the incidence in France of ii choleroe non-O1/non-O139
infection in man has increased since 1996, it remains low (7 cases in 1999)
. After tile death in 1994 of an immunodepressed patient presenting a skin
lesion showing superinfection by a strain of non-O1/non-O139 V. choleroe fo
llowing exposure to seawater, we examined 22 samples of seawater collected
from 20 French coastal areas (Mediterranean coast).
METHODS: The sea-water samples were filtered and enriched with alkaline pep
tone water (APW), and the strains of Vibrio were isolated on TCBS, SS and B
CP media and identified using the API 20 E system (bioMerieux, France).
RESULTS: We isolated 6 strains belonging to 3 species of Vibrio, 2 V. chole
rae (non-O1/non-O139), 3 V. parohoemolyticus and 1 V. alginolyticus. One of
the V. cholerae strains was isolated from sea-water sampled at the coastal
town in which the patient had been staying. The seawater strains exhibited
high sensitivity (MIC determined by agar dilution) to the following antibi
otics : aminoglycosides, tetracyclines, azithromycin, cotrimoxazoie, rifamp
icin and fluoroquinolones. The beta -lactams were very active against strai
ns oi V. cholerae isolated from seawater, while the strain isolated from th
is patient presented a new carbenicillinase (CARB-6) recently described.
CONCLUSION: The presence of Vibrio in seawater along the French coastline c
onstitutes a risk for immunocompromised patients, and the severity of Vibri
o infections warrant improved monitoring both of these organisms and of the
marine environment. In addition, awareness on the part of dodors would all
ow patients at risk to be warned against these dangers.